SUN PHARMA ADVANCED RESEARCH COMPANY Financial Statement Analysis
|
||
The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have increased by 73.98% YoY .
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has increased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Annual Financial Results
[BOM: 532872|NSE : SPARC]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹239 Cr | ₹137 Cr | ₹253 Cr | ₹77 Cr | ₹183 Cr |
Expenses | ₹453 Cr | ₹324 Cr | ₹388 Cr | ₹387 Cr | ₹334 Cr |
Operating Profit (Excl OI) | ₹-214 Cr | ₹-187 Cr | ₹-135 Cr | ₹-310 Cr | ₹-151 Cr |
Other Income | ₹11 Cr | ₹6.85 Cr | ₹5.41 Cr | ₹9.76 Cr | ₹14 Cr |
Interest | ₹7.64 Cr | ₹13 Cr | ₹11 Cr | ₹2.68 Cr | ₹0.09 Cr |
Depreciation | ₹12 Cr | ₹10 Cr | ₹11 Cr | ₹9.48 Cr | ₹7.55 Cr |
Profit Before Tax | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr | ₹-145 Cr |
Profit After Tax | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr | ₹-145 Cr |
Consolidated Net Profit | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr | ₹-145 Cr |
Earnings Per Share (Rs) | ₹-6.86 | ₹-7.48 | ₹-5.77 | ₹-11.92 | ₹-5.55 |
PAT Margin (%) | -93.22 | -148.19 | -59.75 | -406.70 | -79.53 |
ROE(%) | -143.72 | 0.00 | 0.00 | -225.08 | -74.72 |
ROCE(%) | -69.44 | -225.57 | -254.10 | -178.95 | -59.95 |
Total Debt/Equity(x) | 0.00 | -0.37 | -1.37 | -3.59 | 0.01 |
Key Financials |
||
Market Cap | : | ₹ 11,742.0 Cr |
Revenue (TTM) | : | ₹ 106.7 Cr |
Net Profit(TTM) | : | ₹ -363.4 Cr |
EPS (TTM) | : | ₹ -11.2 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
SUN PHARMA ADVANCED RESEARCH COMPANY | -3.6% | 0.7% | 92.3% |
SYNGENE INTERNATIONAL | -1.6% | -10.8% | 16.2% |
BLS INTERNATIONAL SERVICES | 2.7% | -7% | 126.5% |
LATENT VIEW ANALYTICS | -7.4% | -14.2% | 35.7% |
QUESS CORP | 0.8% | -0.4% | 39.6% |
DELTA CORP | -4.2% | -11.9% | -34.5% |
SECURITY AND INTELLIGENCE SERVICES INDIA | -1.4% | 1% | 27.6% |
JUST DIAL | -6.6% | -8.5% | 33.5% |
TEAMLEASE SERVICES | -3.1% | -11.1% | 16.4% |
SUN PHARMA ADVANCED RESEARCH COMPANY Revenues
[BOM: 532872|NSE : SPARC]
Y-o-Y | 73.98 % |
5 Yr CAGR | 6.90 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹239 Cr | 73.98 | |
Mar2022 | ₹137 Cr | -45.74 | |
Mar2021 | ₹253 Cr | 229.31 | |
Mar2020 | ₹77 Cr | -58.00 | |
Mar2019 | ₹183 Cr | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Operating Profit
[BOM: 532872|NSE : SPARC]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹-214 Cr | Negative | |
Mar2022 | ₹-187 Cr | Negative | |
Mar2021 | ₹-135 Cr | Negative | |
Mar2020 | ₹-310 Cr | Negative | |
Mar2019 | ₹-151 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | -89.65% | Negative | |
Mar2022 | -136.07% | Negative | |
Mar2021 | -53.36% | Negative | |
Mar2020 | -403.59% | Negative | |
Mar2019 | -82.73% | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Profit After Tax
[BOM: 532872|NSE : SPARC]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹-223 Cr | Negative | |
Mar2022 | ₹-203 Cr | Negative | |
Mar2021 | ₹-151 Cr | Negative | |
Mar2020 | ₹-312 Cr | Negative | |
Mar2019 | ₹-145 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | -93.22 % | Negative | |
Mar2022 | -148.19 % | Negative | |
Mar2021 | -59.75 % | Negative | |
Mar2020 | -406.7 % | Negative | |
Mar2019 | -79.53 % | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Earnings Per Share (EPS)
[BOM: 532872|NSE : SPARC]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-6.86 | Negative | |
Mar2022 | ₹-7.48 | Negative | |
Mar2021 | ₹-5.77 | Negative | |
Mar2020 | ₹-12 | Negative | |
Mar2019 | ₹-5.55 | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Return on Capital Employed (ROCE)
[BOM: 532872|NSE : SPARC]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | -69.44% | Negative | |
Mar2022 | -225.57% | Negative | |
Mar2021 | -254.1% | Negative | |
Mar2020 | -178.95% | Negative | |
Mar2019 | -59.95% | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
Current Share Price | : | ₹361.9 |
Current MarketCap | : | ₹ 11,742.0 Cr |
Updated EOD on | : | Mar 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMA ADVANCED RESEARCH COMPANY | -3.6% |
0.7% |
92.3% |
SENSEX | -1% |
1% |
24.9% |
SUN PHARMA ADVANCED RESEARCH COMPANY related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | -2.1% | -2.4% | 59.2% |
S&P BSE 500 | -2.2% | -0.9% | 36.5% |
S&P BSE ALLCAP | -2.3% | -1.4% | 38% |
S&P BSE 400 MIDSMALLCAP | -3.8% | -4.8% | 50.6% |
S&P BSE MIDSMALLCAP | -3.9% | -5.5% | 55.7% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | -2.2% | -1% | 37.3% |
NIFTY500 MULTICAP 50:25:25 | -2.8% | -2.6% | 43% |
NIFTY MID SMALL400 | -4% | -5.3% | 52.8% |
NIFTY SMALLCAP250 | -4.3% | -7.5% | 55.6% |
You may also like the below Video Courses
FAQ about SUN PHARMA ADVANCED RESEARCH COMPANY Financials
How the annual revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have changed ?
The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have increased by 73.98% YoY .
How the Earnings per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY have changed?
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has increased by Negative YoY .
SYNGENE INTERNATIONAL LTD vs BLS INTERNATIONAL SERVICES LTD vs LATENT VIEW ANALYTICS LTD
QUESS CORP LTD vs DELTA CORP LTD vs